BNR
Burning Rock Biotech Ltd
NASDAQ: BNR · HEALTHCARE · DIAGNOSTICS & RESEARCH
$17.00
+4.68% today
Updated 2026-04-30
Market cap
$222.76M
P/E ratio
—
P/S ratio
0.41x
EPS (TTM)
$-0.75
Dividend yield
—
52W range
$2 – $42
Volume
0.0M
Burning Rock Biotech Ltd (BNR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-133.70M | $-148.78M | $-228.04M | $-73.54M | $-477.89M | $-456.81M | $-255.78M | $-92.26M |
| Capital expenditures | $23.01M | $24.71M | $45.73M | $79.54M | $213.45M | $62.03M | $9.38M | $5.98M |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $4.05M | $5.09M | $22.79M | $173.22M | $282.43M | $326.78M | $260.72M | $155.62M |
| Free cash flow | $-156.72M | $-173.50M | $-273.77M | $-153.08M | $-691.33M | $-518.84M | $-265.17M | $-98.24M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $360.44M | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |